Literature DB >> 12506369

Mechanism of dioxygen cleavage in tetrahydrobiopterin-dependent amino acid hydroxylases.

Arianna Bassan1, Margareta R A Blomberg, Per E M Siegbahn.   

Abstract

The reaction mechanism for the formation of the hydroxylating intermediate in aromatic amino acid hydroxylases (i.e., phenylalanine hydroxylase, tyrosine hydroxylase, tryptophan hydroxylase) was investigated by means of hybrid density functional theory. These enzymes use molecular oxygen to hydroxylate both the tetrahydrobiopterin cofactor and the aromatic amino acid. A mechanism is proposed in which dioxygen forms a bridging bond between the cofactor and iron. The product is an iron(II)-peroxy-pterin intermediate, and iron was found to be essential for the catalysis of this step. No stable intermediates involving a pterin radical cation and a superoxide ion O(2)(-) were found on the reaction pathway. Heterolysis of the O-O bond in the iron(II)-peroxy-pterin intermediate is promoted by one of the water molecules coordinated to iron and releases hydroxypterin and the high-valent iron oxo species Fe(IV)=O, which can carry out subsequent hydroxylation of aromatic rings. In the proposed mechanism, the formation of the bridging C-O bond is rate-limiting in the formation of Fe(IV)=O.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12506369     DOI: 10.1002/chem.200390006

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  11 in total

Review 1.  Mechanism of aromatic amino acid hydroxylation.

Authors:  Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2003-12-09       Impact factor: 3.162

2.  Exchange-enhanced reactivity in bond activation by metal-oxo enzymes and synthetic reagents.

Authors:  Sason Shaik; Hui Chen; Deepa Janardanan
Journal:  Nat Chem       Date:  2010-12-15       Impact factor: 24.427

3.  Theoretical study of the mechanism of oxoiron(IV) formation from H2O2 and a nonheme iron(II) complex: O-O cleavage involving proton-coupled electron transfer.

Authors:  Hajime Hirao; Feifei Li; Lawrence Que; Keiji Morokuma
Journal:  Inorg Chem       Date:  2011-06-16       Impact factor: 5.165

Review 4.  Mono- and binuclear non-heme iron chemistry from a theoretical perspective.

Authors:  Tibor András Rokob; Jakub Chalupský; Daniel Bím; Prokopis C Andrikopoulos; Martin Srnec; Lubomír Rulíšek
Journal:  J Biol Inorg Chem       Date:  2016-05-26       Impact factor: 3.358

5.  Nature's Machinery, Repurposed: Expanding the Repertoire of Iron-Dependent Oxygenases.

Authors:  Noah P Dunham; Frances H Arnold
Journal:  ACS Catal       Date:  2020-09-28       Impact factor: 13.084

6.  Toxoflavin lyase requires a novel 1-His-2-carboxylate facial triad.

Authors:  Michael K Fenwick; Benjamin Philmus; Tadhg P Begley; Steven E Ealick
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

7.  Theoretical study of the reduction of nitric oxide in an A-type flavoprotein.

Authors:  L Mattias Blomberg; Margareta R A Blomberg; Per E M Siegbahn
Journal:  J Biol Inorg Chem       Date:  2006-09-07       Impact factor: 3.358

8.  A comparison of the reaction mechanisms of iron- and manganese-containing 2,3-HPCD: an important spin transition for manganese.

Authors:  Valentin Georgiev; Tomasz Borowski; Margareta R A Blomberg; Per E M Siegbahn
Journal:  J Biol Inorg Chem       Date:  2008-05-06       Impact factor: 3.358

9.  Could the tyrosine-histidine ligand to CuB in cytochrome c oxidase be coordinatively labile? Implications from a quantum chemical model study of histidine substitutional lability and the effects of the covalent tyrosine-histidine cross-link.

Authors:  Stephen B Colbran; Michael N Paddon-Row
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

10.  Role of the second coordination sphere residue tyrosine 179 in substrate affinity and catalytic activity of phenylalanine hydroxylase.

Authors:  Jérôme Zoidakis; Mui Sam; Alon Volner; Andrew Han; Kim Vu; Mahdi M Abu-Omar
Journal:  J Biol Inorg Chem       Date:  2004-03-04       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.